Drug
Paclitaxel Bevacizumab Therapy
Paclitaxel Bevacizumab Therapy: highest development phase Phase 3, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Paclitaxel + bevacizumab therapy NCT04732598 | Phase 3 | Breast Cancer |
Latest
No recent events.
Follow Paclitaxel Bevacizumab Therapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.